A patient was transferred to Harborview from another hospital in late June, and tests later showed the patient had brucellosis. A lab worker also dropped a test tube with the Brucella bacteria in it on June 25, which may have exposed other lab employees.
The Harborview employees have been offered antibiotics and blood tests and informed of the symptoms, which include fever, headache, and muscle and joint pain. Brucella can be deadly if left untreated. The disease does not spread person to person, however, so hospital patients, other employees, and exposed employees’ families are not in danger of catching it.
So far, employees’ blood tests for Brucella bacteria have come back negative.
More articles on clinical leadership and infection control:
Jewish Hospital to suspend heart transplant program
Kansas requires meningitis, hep A vaccines for school-aged children
2 injured in explosion at Connecticut hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
